OBJECTIVE: This study sought to determine whether health outcomes differed by gender in a cohort of African American, Hispanic American, and white drug users. METHODS: The authors studied hospitalization rates and discharge diagnoses in the HERO Study, an ongoing prospective study of drug users that included HIV-positive and HIV-negative opiate users. The data are from 1996-2000, when highly active antiretroviral therapy (HAART) was available. RESULTS: Women had higher rates of hospitalization than men independent of HIV status, and there was no association between ethnicity and hospitalization. Being a woman was an independent risk factor for HIV and non-HIV-related hospitalization. CONCLUSION: Health disparities between men and women extend to HIV.
OBJECTIVE: This study sought to determine whether health outcomes differed by gender in a cohort of African American, Hispanic American, and white drug users. METHODS: The authors studied hospitalization rates and discharge diagnoses in the HERO Study, an ongoing prospective study of drug users that included HIV-positive and HIV-negative opiate users. The data are from 1996-2000, when highly active antiretroviral therapy (HAART) was available. RESULTS:Women had higher rates of hospitalization than men independent of HIV status, and there was no association between ethnicity and hospitalization. Being a woman was an independent risk factor for HIV and non-HIV-related hospitalization. CONCLUSION: Health disparities between men and women extend to HIV.
Authors: A Mocroft; S Madge; A M Johnson; A Lazzarin; N Clumeck; F D Goebel; J P Viard; J Gatell; A Blaxhult; J D Lundgren Journal: J Acquir Immune Defic Syndr Date: 1999-12-01 Impact factor: 3.731
Authors: Y Mouton; S Alfandari; M Valette; F Cartier; P Dellamonica; G Humbert; J M Lang; P Massip; D Mechali; P Leclercq; J Modai; H Portier Journal: AIDS Date: 1997-10 Impact factor: 4.177
Authors: M F Shapiro; S C Morton; D F McCaffrey; J W Senterfitt; J A Fleishman; J F Perlman; L A Athey; J W Keesey; D P Goldman; S H Berry; S A Bozzette Journal: JAMA Date: 1999 Jun 23-30 Impact factor: 56.272
Authors: S Bassetti; M Battegay; H Furrer; M Rickenbach; M Flepp; L Kaiser; A Telenti; P L Vernazza; E Bernasconi; P Sudre Journal: J Acquir Immune Defic Syndr Date: 1999-06-01 Impact factor: 3.731
Authors: P A Selwyn; P Alcabes; D Hartel; D Buono; E E Schoenbaum; R S Klein; K Davenny; G H Friedland Journal: N Engl J Med Date: 1992-12-10 Impact factor: 91.245
Authors: R Detels; A Muñoz; G McFarlane; L A Kingsley; J B Margolick; J Giorgi; L K Schrager; J P Phair Journal: JAMA Date: 1998-11-04 Impact factor: 56.272
Authors: Karen Shiu-Yee; Ahnalee M Brincks; Daniel J Feaster; Jemima A Frimpong; Ank Nijhawan; Raul N Mandler; Robert Schwartz; Carlos Del Rio; Lisa R Metsch Journal: AIDS Behav Date: 2018-09
Authors: Anna L Hotton; Kathleen M Weber; Ronald C Hershow; Kathryn Anastos; Peter Bacchetti; Elizabeth T Golub; Deborah Gustafson; Alexandra M Levine; Mary Young; Mardge H Cohen Journal: J Acquir Immune Defic Syndr Date: 2017-06-01 Impact factor: 3.731
Authors: Baligh R Yehia; John A Fleishman; Perrin L Hicks; Michelande Ridore; Richard D Moore; Kelly A Gebo Journal: J Acquir Immune Defic Syndr Date: 2010-03 Impact factor: 3.731
Authors: Philip Todd Korthuis; Joshua S Josephs; John A Fleishman; James Hellinger; Seth Himelhoch; Geetanjali Chander; Elizabeth B Morse; Kelly A Gebo Journal: J Subst Abuse Treat Date: 2008-03-07
Authors: George E Fryer; Larry A Green; Susan M Dovey; Barbara P Yawn; Robert L Phillips; David Lanier Journal: Ann Fam Med Date: 2003 Jul-Aug Impact factor: 5.166
Authors: Dan Lewer; Joseph Freer; Emma King; Sarah Larney; Louisa Degenhardt; Emily J Tweed; Vivian D Hope; Magdalena Harris; Tim Millar; Andrew Hayward; Dan Ciccarone; Katherine I Morley Journal: Addiction Date: 2020-02-10 Impact factor: 7.256
Authors: Vanessa Castro-Granell; María José Fuster-RuizdeApodaca; Noé Garin; Ángeles Jaén; José Luis Casado; Lorna Leal; Santiago Cenoz Journal: AIDS Behav Date: 2021-05-01